Shares of Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) are trading higher Monday after the pharmaceutical company reported positive data from an ongoing trial. What To Know: Recursion ...

In early December 2025, Recursion Pharmaceuticals released clinical data from the TUPELO Phase 1b/2 trial of REC-4881, providing fresh insight into the candidate’s safety and efficacy profile. This ...

Recursion Pharmaceuticals (RXRX) is drawing renewed attention after the appointment of Najat Khan as CEO and news of a narrowing net loss, both viewed as signals of improving execution. Investors also ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.45. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

The data is starting to reveal how galaxies and their black holes evolve. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. After only one year of ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

It's almost become expected that many space telescopes and probes can have "extended missions." Both Voyagers are still sending data back 40+ years after their five-year primary mission ended. But ...

Astronomers using data from ESA's Euclid and Herschel space telescopes have confirmed that star formation has already peaked in the cosmos, and that the universe is bound to get steadily 'colder and ...

EUCLID, Ohio — Euclid voters returned familiar faces to City Council on Tuesday, with most races decided by wide margins, according to unofficial results from the Cuyahoga County Board of Elections.

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...

The consortium running the European Space Agency's (ESA) Euclid mission has published the most extensive simulation of the cosmos to date. The modeling was based on algorithms developed by UZH ...

RXRX stock looks like a deep-value growth bet at just $5 and change. Though the technology is exciting, I’m not rushing into shares just yet. Nvidia made early investors rich, but there is a new class ...